Hypoxia Controls the Glycome Signature and Galectin-8–Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma
Year: 2022
Type: article
Authors: Asmi Chakraborty, Mariana Perez, Jordan D. Carroll, Aristotelis Antonopoulos, Anne Dell, Liettel Ortega, Norhan B.B. Mohammed, Michael Wells, Caleb Staudinger, Anthony Griswold, Kevin B. Chandler, Cristina Marrero, Ramon Jimenez, Yoshihiko Tani, James S. Wilmott, John F. Thompson, Wei Wang, Robert Sackstein, Richard A. Scolyer, George F. Murphy, Stuart M. Haslam, Charles J. Dimitroff
Institutions: Florida International University, Imperial College London, South Valley University, Case Western Reserve University, University of Miami, Baptist Health South Florida, Japanese Red Cross Society, Japan, The University of Sydney, Melanoma Institute Australia, Royal Prince Alfred Hospital, Brigham and Women's Hospital, Harvard University, NSW Health Pathology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funders: Pharmaceutical Research and Manufacturers of America Foundation, Wellcome Trust, Rochester Academy of Science, LEO Fondet, Melanoma Institute Australia, National Institutes of Health, Directorate for Biological Sciences, MSD Australia, Medical Research Council, Biotechnology and Biological Sciences Research Council, National Health and Medical Research Council, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases
Awards: Improving clinical outcomes of melanoma patients, G2513989095, Molecular determinants of risk, progression and treatment response in melanoma, Core support for collaborative glycomic and proteomic research, G469863015, G4950536974, G5430074932, G6230832641, Glycomic characterization of avian influenza binding sites in the respiratory tract of humans and susceptible animals., G7582807800, G9000073832, G9000250330, Analysis of vascular Galectin-9 as an immunomodulator of B-cell activity
OpenAlex ID: W4297399547